Medifast Inc
MED11.398USD
-0.452-3.81%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
125.28MMarktkapitalisierung
498.16KGV TTM
mehr Informationen über Medifast Inc Unternehmen
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Medifast Inc Informationen
BörsenkürzelMED
Name des UnternehmensMedifast Inc
IPO-datumDec 30, 1993
CEOChard (Daniel R)
Anzahl der mitarbeiter504
WertpapierartOrdinary Share
GeschäftsjahresendeDec 30
Addresse100 International Drive, 18th Floor
StadtBALTIMORE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl21202
Telefon14105818042
Websitehttps://medifastinc.com/
BörsenkürzelMED
IPO-datumDec 30, 1993
CEOChard (Daniel R)
Führungskräfte von Medifast Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Elizabeth A. Geary
Ms. Elizabeth A. Geary
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
164.95K
-39.55%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.02K
+86.92%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
13.91K
+12.00%
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Jonathan B. Mackenzie
Mr. Jonathan B. Mackenzie
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
--
--
Umsatzaufteilung
FY2025Q2
FY2025Q1
FY2024
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
105.56M
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Tue, Nov 18
Aktualisiert: Tue, Nov 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Andere
69.09%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
7.62%
Renaissance Technologies LLC
7.29%
The Vanguard Group, Inc.
6.47%
Charles Schwab Investment Management, Inc.
5.42%
BofA Global Research (US)
4.12%
Andere
69.09%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
34.59%
Investment Advisor/Hedge Fund
25.52%
Hedge Fund
17.51%
Research Firm
7.05%
Individual Investor
3.30%
Family Office
0.88%
Pension Fund
0.13%
Bank and Trust
0.12%
Insurance Company
0.03%
Andere
10.85%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
470
8.80M
80.10%
-3.51M
2025Q2
501
8.65M
78.71%
-4.63M
2025Q1
543
8.84M
80.44%
-4.55M
2024Q4
558
9.50M
86.82%
-4.11M
2024Q3
566
9.73M
88.98%
-4.84M
2024Q2
601
11.02M
100.79%
-3.10M
2024Q1
608
12.20M
111.59%
-579.67K
2023Q4
629
10.91M
100.15%
-1.24M
2023Q3
641
10.20M
93.63%
-1.89M
2023Q2
664
10.18M
93.46%
-1.94M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
799.27K
7.27%
-56.13K
-6.56%
Jun 30, 2025
Renaissance Technologies LLC
813.31K
7.4%
-75.62K
-8.51%
Jun 30, 2025
The Vanguard Group, Inc.
795.45K
7.24%
+31.89K
+4.18%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
421.17K
3.83%
+155.60K
+58.59%
Jun 30, 2025
BofA Global Research (US)
396.37K
3.61%
+107.85K
+37.38%
Jun 30, 2025
Two Sigma Investments, LP
419.02K
3.81%
-16.70K
-3.83%
Jun 30, 2025
Acadian Asset Management LLC
411.10K
3.74%
+25.38K
+6.58%
Jun 30, 2025
Parametric Portfolio Associates LLC
323.67K
2.94%
+108.94K
+50.73%
Jun 30, 2025
AQR Capital Management, LLC
220.13K
2%
+20.38K
+10.20%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
Acquirers Small and Micro Deep Value ETF
0.79%
Federated Hermes MDT Small Cap Core ETF
0.19%
First Trust Active Factor Small Cap ETF
0.15%
iShares US Small Cap Value Factor ETF
0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.12%
Schwab Fundamental U.S. Small Company ETF
0.06%
iShares US Small-Cap Equity Factor ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.02%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Mehr Anzeigen
Acquirers Small and Micro Deep Value ETF
Anteil0.79%
Federated Hermes MDT Small Cap Core ETF
Anteil0.19%
First Trust Active Factor Small Cap ETF
Anteil0.15%
iShares US Small Cap Value Factor ETF
Anteil0.15%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Anteil0.12%
Schwab Fundamental U.S. Small Company ETF
Anteil0.06%
iShares US Small-Cap Equity Factor ETF
Anteil0.04%
Franklin US Small Cap Multifactor Index ETF
Anteil0.02%
iShares Micro-Cap ETF
Anteil0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
262.40M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Sep 07, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Nov 07, 2023 going ex on Sep 18, 2023
Sep 19, 2023
Nov 07, 2023
Sep 18, 2023
Jun 15, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on Aug 08, 2023 going ex on Jun 26, 2023
Jun 27, 2023
Aug 08, 2023
Jun 26, 2023
Mar 16, 2023
MED.NB Interim Cash Dividend of gross USD 1.65 paid on May 09, 2023 going ex on Mar 27, 2023
Mar 28, 2023
May 09, 2023
Mar 27, 2023
Dec 08, 2022
MED.NB Final Cash Dividend of gross USD 1.64 paid on Feb 07, 2023 going ex on Dec 19, 2022
Dec 20, 2022
Feb 07, 2023
Dec 19, 2022
Sep 08, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Nov 08, 2022 going ex on Sep 19, 2022
Sep 20, 2022
Nov 08, 2022
Sep 19, 2022
Jun 16, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on Aug 08, 2022 going ex on Jun 27, 2022
Jun 28, 2022
Aug 08, 2022
Jun 27, 2022
Mar 17, 2022
MED.NB Interim Cash Dividend of gross USD 1.64 paid on May 09, 2022 going ex on Mar 28, 2022
Mar 29, 2022
May 09, 2022
Mar 28, 2022
Dec 08, 2021
MED.NB Final Cash Dividend of gross USD 1.42 paid on Feb 08, 2022 going ex on Dec 20, 2021
Dec 21, 2021
Feb 08, 2022
Dec 20, 2021
Sep 09, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Nov 08, 2021 going ex on Sep 20, 2021
Sep 21, 2021
Nov 08, 2021
Sep 20, 2021
Jun 03, 2021
MED.NB Interim Cash Dividend of gross USD 1.42 paid on Aug 06, 2021 going ex on Jun 21, 2021
Jun 22, 2021
Aug 06, 2021
Jun 21, 2021
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Medifast Inc?
Die fünf größten Anteilseigner von Medifast Inc sind:
BlackRock Institutional Trust Company, N.A. hält 799.27K Aktien, was 7.27% der Gesamtaktien entspricht.
Renaissance Technologies LLC hält 813.31K Aktien, was 7.40% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 795.45K Aktien, was 7.24% der Gesamtaktien entspricht.
Charles Schwab Investment Management, Inc. hält 421.17K Aktien, was 3.83% der Gesamtaktien entspricht.
BofA Global Research (US) hält 396.37K Aktien, was 3.61% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 799.27K Aktien, was 7.27% der Gesamtaktien entspricht.
Renaissance Technologies LLC hält 813.31K Aktien, was 7.40% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 795.45K Aktien, was 7.24% der Gesamtaktien entspricht.
Charles Schwab Investment Management, Inc. hält 421.17K Aktien, was 3.83% der Gesamtaktien entspricht.
BofA Global Research (US) hält 396.37K Aktien, was 3.61% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Medifast Inc?
Die drei wichtigsten Anteilseigner-Typen von Medifast Inc sind:
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
The Vanguard Group, Inc.
Wie viele Institutionen halten Anteile an Medifast Inc (MED)?
Mit Stand vom 2025Q3 halten 470 Institutionen Anteile an Medifast Inc, mit einem Gesamtmarktwert von etwa 8.80M, was 80.10% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um 1.39% gestiegen.
Was ist die größte Einnahmequelle von Medifast Inc?
Am FY2025Q2 erzielte das Geschäft mit -- für Medifast Inc den höchsten Umsatz in Höhe von --, was --% des Gesamtumsatzes entspricht.
